Mepolizumab Beneficial in COPD With Eosinophilic Phenotype
Lower annual rate of moderate, severe exacerbations for patients receiving 100 mg mepolizumab
Are Physicians Obligated to Help on Planes?
One administrative physician explains his sense of obligation to help
Distal Bicep Tendon Rip Tied to Transthyretin Amyloidosis
Findings in patients with heart failure with preserved ejection fraction
Online Therapy for Insomnia Linked to Improved Mental Health
University students undergoing online CBT program had reductions in insomnia, paranoia, hallucinations
Longer Progression-Free Survival for Durvalumab in NSCLC
Longer median progression-free survival from randomization, higher response rate with durvalumab
‘Modest at Best’ Discriminatory Ability for CBC Test in Infants
Findings among febrile infants (≤60 days) with invasive bacterial infections
Median Cost of Cancer Drug Development $648.0 Million
Total revenue from sales of 10 drugs was $67.0 billion, with total R&D spending of $7.2 billion
AAO-HNS: Improvement in OSA With Cranial Nerve Stimulation
Decrease in apnea-hypopnea index, and improvement in oxygen saturation, sleepiness, quality of life
Center Surgical Volume Linked to LVAD Patient Outcomes
Worse survival at centers performing ≤10 left ventricular assist device implants/year
Airway Mucin Concentrations May Help Predict Chronic Bronchitis
Mean total mucin concentrations up in smokers with severe COPD, those with respiratory exacerbations
